-
Published16/07/2024
-
Deadline19/08/2024
-
Opening of tenders19/08/2024
-
Awarded27/09/2024
-
Today07/10/2026
Utilities
- indicates text translated automatically in your browsing language
Successive supply of reagents with the lease of immunohistochemical diagnostic test equipment for the Maria Skłodowska-Curie National Institute of Oncology – National Research Institute, Gliwice Branch, hereinafter referred to as the Contracting Authority
1.The subject-matter of this contract is the successive supply of reagents together with the lease of immunohistochemical diagnostic test equipment for the Maria Skłodowska-Curie National Institute of Oncology – National Research Institute, Gliwice Branch, hereinafter referred to as the Contracting Authority. 2. Detailed information on the present proceedings is contained in the SWZ. 3. The proceedings do not include the objections set out in Article 94 of the Public Procurement Act. 4. Information on joint bids by contractors is provided in Chapter IX of the SWZ. 5. Information clause resulting from the content of Article 13 of Regulation (EU) 2016/679 of the European Parliament and of the Council of 27 April 2016 on the protection of natural persons with regard to the processing of personal data and on the free movement of such data, and repealing Directive 95/46/EC, the Ordering Party has included in the SWZ
https://ezamowienia.gov.pl/mp-client/search/list/ocds-148610-de420e11-5b23-4330-85f2-2fa28ac2a108
https://ezamowienia.gov.pl/mp-client/search/list/ocds-148610-de420e11-5b23-4330-85f2-2fa28ac2a108
Type: price
Description: cena
Weight (percentage, exact):
This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.